New MD at Meda

New MD at Meda Agreement has been reached between Managing Director Göran Pettersson and the Board of Directors concerning the MD's departure from Meda AB. The Board will immediately begin looking for a new MD who will manage Meda once the merger with Cross Pharma has been completed. Göran Pettersson will remain in his current position until a new MD is appointed. The Board anticipates that the new MD will be in place before the end of the year. The merger process continues The Board has decided to re-locate Meda's head office and pharmaceuticals business to Stockholm. The Hospital Care business unit will remain in Gothenburg. Due to the law concerning right of participation in decision- making, negotiations concerning the move from Gothenburg to Stockholm has started. For further information, please contact Per Carendi Chairman of the Board Phone + 46 36 10 07 00 or +46 708 11 21 11 Meda develops profitable partnerships in the Nordic and Baltic areas in collaboration with international producers of pharmaceuticals, nutrition and medical device products. With our thorough knowledge and expertise in sales and marketing, we offer benefits to the health and medical care sector at the same time as we promote both our own and our partners' growth and development. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/09/16/19990916BIT00540/bit0001.doc http://www.bit.se/bitonline/1999/09/16/19990916BIT00540/bit0002.pdf

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.

Subscribe